Patent · US Active

C-Met modulator pharmaceutical compositions

US10039757B2 · kind B2 · utility

26Cited by
11References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 7, 2017
Grant dateAug 7, 2018
Priority date—
Expiry dateFeb 7, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/2866
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pharmaceutical compositions and unit dosage forms comprising Compound I are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.